Drug lowers high potassium levels associated with potentially lethal cardiac arrhythmias
Monday, November 17, 2014 - 19:02
in Health & Medicine
Researchers evaluated the efficacy and safety of the drug zirconium cyclosilicate in patients with hyperkalemia -- higher than normal potassium levels. Hyperkalemia is a common electrolyte disorder which can cause potentially life-threatening cardiac arrhythmias and is associated with chronic kidney disease, heart failure, and diabetes mellitus.